|
Wednesday 1st July 2020 |
Text too small? |
AFT Pharmaceuticals Limited (NZX: AFT /ASX:AFP) (AFT) announced today that its NZ$2 million share purchase plan (SPP) has closed oversubscribed. The SPP received strong shareholder support with AFT receiving applications totalling approximately NZ$9.8 million. Applications will be scaled on a proportionate basis in accordance with the number of AFT shares held by applicants on the SPP record date (9 June 2020). Refunds of surplus application amounts paid will be made to applicants in accordance with the terms of the SPP offer document. See link below for detail.
No comments yet
August 7th Morning Report
PHL - Promisia to acquire Chatswood Retirement Village
MEL - Annual Shareholder Meeting 2026 / Director Nominations
August 6th Morning Report
General Capital (NZX: GEN) Announces Credit Rating Upgrade
August 4th Morning Report
Devon Funds Morning Note - 03 August 2026
GEN - General Capital gives Notice of Annual Meeting 2026
AFT Chair David Flacks to retire before the next ASM
PCT - Precinct NZ $65 million Wholesale Bond Issue